VACCINE INFORMATION CENTER
Third Trimester Immunization With Tdap Vaccine Optimal for Pertussis Toxin Antibody Concentrations in Newborns
Immunization with Tdap vaccine during the third trimester of pregnancy resulted in higher concentrations of pertussis toxin antibodies in newborns.
The burden of childhood and infant pneumonia can be effectively reduced through the use of the pneumococcal Haemophilus influenzae protein D conjugate vaccine.
The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.
Even if the flu shot "misses," as it did last year, it remains one of the best tools we have to help our patients live healthier lives.
Clinicians should inform parents about the safety of vaccines to encourage them to vaccinate their children.
Common reasons that parents give when declining human papillomavirus vaccine for their children are, "My teen is not sexually active," or "Maybe we'll wait until he/she is a bit older." This thinking negates the vaccine's preventive purpose.
With the advent of platform manufacturing technology, vaccines can be developed quickly to stop the spread of outbreaks.
NIH's National Institute of Allergy and Infectious Diseases is researching ways to develop a universal influenza vaccine against multiple strains.